Stocks › ABT

ABBOTT LABORATORIES

ABT·NYSE·United States United States·USD
$103.00
-0.87 (-0.84%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
ABT
ABBOTT LABORATORIES · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ABTS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of ABT by members of U.S. Congress · 402 on record · 54 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Ro KhannaRo KhannaHouse · D · CA ABTABBOTT LABORATORIES · Common Stock Purchase
Nov 5, 2026 Oct 7, 2026 Filing ↗
Thomas H. Kean, Jr.Thomas H. Kean, Jr.House · R · NJ ABTABBOTT LABORATORIES · Stock Sale
$1,001 - $15,000
Oct 30, 2026 Sep 17, 2026 Filing ↗
Pete SessionsPete SessionsHouse · R · TX ABTABBOTT LABORATORIES · Stock Sale
$50,001 - $100,000
Oct 27, 2026 Oct 2, 2026 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA ABTABBOTT LABORATORIES · Stock Purchase
$1,001 - $15,000
Oct 12, 2026 Sep 18, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA ABTABBOTT LABORATORIES · Common Stock Purchase
$1,001 - $15,000
Oct 8, 2026 Sep 4, 2026 Filing ↗
Rick W. AllenRick W. AllenHouse · R · GA ABTABBOTT LABORATORIES · Stock Sale
$15,001 - $50,000
Aug 18, 2026 Jul 14, 2026 Filing ↗
Richard McCormickRichard McCormickHouse · R · GA ABTABBOTT LABORATORIES · Stock Sale
$1,001 - $15,000
Aug 14, 2026 Jul 30, 2026 Filing ↗
Mike KellyMike KellyHouse · R · PA ABTABBOTT LABORATORIES · Stock Sale
$1,001 - $15,000
Aug 12, 2026 Jul 17, 2026 Filing ↗
Alan ArmstrongAlan ArmstrongSenate · R · OK ABTABBOTT LABORATORIES · Stock Sale
$15,001 - $50,000
Jul 21, 2026 Mar 27, 2026 Filing ↗
Rick LarsenRick LarsenHouse · D · WA ABTABBOTT LABORATORIES · Stock Sale
$1,001 - $15,000
Jul 12, 2026 Jul 8, 2026 Filing ↗
Richard McCormickRichard McCormickHouse · R · GA ABTABBOTT LABORATORIES · Stock Purchase
$1,001 - $15,000
Jul 9, 2026 Jun 12, 2026 Filing ↗
Richard McCormickRichard McCormickHouse · R · GA ABTABBOTT LABORATORIES · Stock Purchase
$1,001 - $15,000
Jul 9, 2026 Jun 12, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA ABTABBOTT LABORATORIES · Common Stock Purchase
$1,001 - $15,000
Jul 7, 2026 Jun 2, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA ABTABBOTT LABORATORIES · Stock Sale
$1,001 - $15,000
Jul 7, 2026 Jun 23, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA ABTABBOTT LABORATORIES · Stock Purchase
$1,001 - $15,000
Jul 7, 2026 Jun 30, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA ABTABBOTT LABORATORIES · Stock Sale
$1,001 - $15,000
Jul 7, 2026 Jun 23, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA ABTABBOTT LABORATORIES · Stock Sale
$1,001 - $15,000
Jul 7, 2026 Jun 23, 2026 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA ABTABBOTT LABORATORIES · Stock Purchase
$1,001 - $15,000
Jul 2, 2026 Jun 16, 2026 Filing ↗
Julie JohnsonJulie JohnsonHouse · D · TX ABTABBOTT LABORATORIES · Stock Sale
$1,001 - $15,000
Jun 12, 2026 May 12, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA ABTABBOTT LABORATORIES · Common Stock Purchase
$15,001 - $50,000
Jun 10, 2026 May 15, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA ABTABBOTT LABORATORIES · Stock Purchase
$15,001 - $50,000
Jun 10, 2026 May 1, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA ABTABBOTT LABORATORIES · Stock Sale
$15,001 - $50,000
Jun 10, 2026 May 27, 2026 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA ABTABBOTT LABORATORIES · Stock Sale
$1,001 - $15,000
Jun 8, 2026 May 15, 2026 Filing ↗
Rick W. AllenRick W. AllenHouse · R · GA ABTABBOTT LABORATORIES · Stock Sale
$15,001 - $50,000
Jun 5, 2026 Apr 16, 2026 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ ABTABBOTT LABORATORIES · Stock Sale
$1,001 - $15,000
Jun 3, 2026 May 27, 2026 Filing ↗

Whale Activity

Position changes in ABT reported for 2026-09-30 by 3164 institutional filers
Increased: 1202New: 211Held: 383Decreased: 1130Closed: 118No prior filing: 120
  • Increased1202
  • New211
  • Held383
  • Decreased1130
  • Closed118
  • No prior filing120
FilerSharesValueChange
BlackRock, Inc.151.7M$14.99Bdecreased
VANGUARD CAPITAL MANAGEMENT LLC113.3M$11.19Bdecreased
STATE STREET CORP81.4M$8.05Bincreased
CHARLES SCHWAB INVESTMENT MANAGEMENT INC57.2M$5.65Bdecreased
VANGUARD PORTFOLIO MANAGEMENT LLC47.9M$4.74Bdecreased
Capital Research Global Investors45.0M$4.45Bincreased
GEODE CAPITAL MANAGEMENT, LLC39.6M$3.89Bincreased
Capital International Investors35.5M$3.51Bincreased
JPMORGAN CHASE & CO29.7M$3.00Bincreased
MORGAN STANLEY28.9M$2.86Bincreased
FRANKLIN TEMPLETON INC20.4M$2.36Bincreased
PRICE T ROWE ASSOCIATES INC /MD/23.5M$2.33Bincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by ABT insiders, by quarter · Form 4
-1.0M-500.0K0500.0K1.0M2025 Q1: -596.9K2025 Q12025 Q2: -2,6002025 Q22025 Q3: -5,5502025 Q32025 Q4: -1,5862025 Q42026 Q1: 24.6K2026 Q12026 Q2: 14.2K2026 Q22026 Q3: -404.7K2026 Q32026 Q4: -3,5002026 Q4

Recent Insider Transactions

6,440 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Moreland Mary KEXECUTIVE VICE PRESIDENT Sale −3,500 $116.00 $406K Nov 5, 2026 Form 4 ↗
Conroy Kevin TDirector Tax withholding −52.5K $103.99 $5.5M Sep 23, 2026 Form 4 ↗
MCCOY JOHN A. JR.VICE PRESIDENT AND CONTROLLER Sale −27 $109.54 $3K Sep 2, 2026 Form 4 ↗
Boudreau Philip PEVP AND CFO Tax withholding −388 $110.36 $43K Sep 1, 2026 Form 4 ↗
MCCOY JOHN A. JR.VICE PRESIDENT AND CONTROLLER Tax withholding −52 $110.36 $6K Sep 1, 2026 Form 4 ↗
Ford Robert BCHAIRMAN AND CEO · Director Sale −180.3K $116.19 $20.9M Aug 25, 2026 Form 4 ↗
Ford Robert BCHAIRMAN AND CEO · Director Sale −218.5K $115.57 $25.3M Aug 25, 2026 Form 4 ↗
Ford Robert BCHAIRMAN AND CEO · Director Option exercise +247.0K $59.94 $14.8M Aug 25, 2026 Form 4 ↗
Ford Robert BCHAIRMAN AND CEO · Director Option exercise +151.9K $44.40 $6.7M Aug 25, 2026 Form 4 ↗
Morrone Louis H.EXECUTIVE VICE PRESIDENT Discretionary −12 $107.99 $1K Aug 12, 2026 Form 4 ↗
Morrone Louis H.EXECUTIVE VICE PRESIDENT Sale −5,850 $109.83 $643K Aug 11, 2026 Form 4 ↗
Morrone Louis H.EXECUTIVE VICE PRESIDENT Tax withholding −269 $92.71 $25K Jun 30, 2026 Form 4 ↗
Cushman Elizabeth C.EVP, GC AND SECRETARY Tax withholding −560 $94.12 $53K Jun 27, 2026 Form 4 ↗
Stratton John GDirector Purchase +2,000 $86.82 $174K May 7, 2026 Form 4 ↗
Moreland Mary KEXECUTIVE VICE PRESIDENT Discretionary +5,314 $94.41 $502K Apr 28, 2026 Form 4 ↗
STARKS DANIEL JDirector Purchase +10.0K $92.65 $927K Apr 27, 2026 Form 4 ↗
Ahuja NitaDirector Grant / award +2,286 $0.00 $0 Apr 24, 2026 Form 4 ↗
Gonzalez Patricia PaolaDirector Grant / award +2,286 $0.00 $0 Apr 24, 2026 Form 4 ↗
McDew Darren WDirector Grant / award +2,286 $0.00 $0 Apr 24, 2026 Form 4 ↗
Babineaux-Fontenot ClaireDirector Grant / award +2,286 $0.00 $0 Apr 24, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding ABT · SEC Form N-PORT
FundSharesValue% of fundAs of
Schwab U.S. Dividend Equity ETF
SCHWAB STRATEGIC TRUST
47.6M$5.26B4.68%Aug 31, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
55.3M$5.02B0.22%Jun 30, 2026
VANGUARD 500 INDEX FUND
VANGUARD INDEX FUNDS
45.1M$4.10B0.25%Jun 30, 2026
Fidelity 500 Index Fund
Fidelity Concord Street Trust
22.6M$2.50B0.29%Aug 31, 2026
iShares Core S&P 500 ETF
iShares Trust
24.0M$2.17B0.24%Jun 30, 2026
State Street(R) SPDR(R) S&P 500(R) ETF Trust21.1M$1.92B0.25%Jun 30, 2026
Washington Mutual Investors Fund17.5M$1.85B0.85%Jul 31, 2026
VANGUARD VALUE INDEX FUND
VANGUARD INDEX FUNDS
16.6M$1.50B0.59%Jun 30, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF
SELECT SECTOR SPDR TRUST
12.3M$1.12B2.75%Jun 30, 2026
VANGUARD DIVIDEND APPRECIATION INDEX FUND
VANGUARD SPECIALIZED FUNDS
9.9M$1.04B0.80%Jul 31, 2026

Mutual funds and ETFs whose N-PORT filings list ABT's shares (CUSIP 002824100), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings

No 13D/13G beneficial-ownership filings on record.

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming abbott laboratories as client
$0$2.5M$5.0M$7.5M$10.0M2023 Q1: $2.4M2023 Q2: $1.1M2023 Q3: $1.4M2023 Q4: $1.1M20232024 Q1: $1.7M2024 Q2: $1.2M2024 Q3: $1.4M2024 Q4: $2.4M20242025 Q1: $2.1M2025 Q2: $1.2M2025 Q3: $1.5M2025 Q4: $1.2M20252026 Q1: $1.8M2026 Q2: $1.5M2026 Q3: $1.7M2026
  • PHRONESISDC, LLCABBOTT LABORATORIES · 2026 Q3 · TAX, RET$50K
    Filing ↗
  • DUDDINGTON GLOBAL STRATEGIES LLCABBOTT LABORATORIES · 2026 Q3 · VET$10K
    Filing ↗
  • MARSHALL & POPP, LLCABBOTT LABORATORIES · 2026 Q3 · TAX, DEF, HCR, TRD$60K
    Filing ↗
  • THE DUBERSTEIN GROUP INC.ABBOTT LABORATORIES · 2026 Q3—
    Filing ↗
  • ABBOTT LABORATORIESABBOTT LABORATORIES · 2026 Q3 · HCR, MMM, TRD, LAW$1.3M
    Filing ↗

Government Contracts

Federal awards to abbott laboratories · USAspending
$261.3MAwarded · 452 contracts on record
  • Department of StateMEDICAL SUPPLIES$21K
    Sep 29, 2026 · ↗
  • Department of StateMEDICAL SUPPLIES$21K
    Sep 14, 2026 · ↗
  • Department of Health and Human ServicesEO 14398 ALINITY MAINTENANCE AND SUPPLIES$325K
    Jun 26, 2026 · ↗
  • Department of Veterans AffairsABBOTT ENSITE AND CLARIS ANNUAL PM SERVICES BASE YEAR$86K
    Mar 14, 2025 · ↗
  • Department of Veterans AffairsARCHITECT REAGENT ORDER$95K
    Jul 1, 2025 · ↗
  • Department of Veterans AffairsISTAT POINT OF CARE SYSTEM$3.1M
    Mar 15, 2022 · ↗
  • Department of Veterans AffairsREGENTS$249K
    Oct 1, 2024 · ↗
  • Department of Veterans AffairsNTX IMMUNOASSAY CPT - ORDER 1$309K
    Jul 1, 2025 · ↗

U.S. Patents

Recent USPTO applications naming ABBOTT LABORATORIES

No USPTO patent applications found for ABBOTT LABORATORIES.

Annual Financials

From ABT's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$44.33B$41.95B$40.11B$43.65B$43.08B
Operating income$8.05B$6.83B$6.48B$8.36B$8.43B
Net income$6.52B$13.40B$5.72B$6.93B$7.07B
Diluted EPS$3.72$7.64$3.26$3.91$3.94
Operating cash flow$9.57B$8.56B$7.26B$9.58B$10.53B
Cash and equivalents$8.52B$7.62B$6.90B$9.88B$9.80B
Total assets$86.71B$81.41B$73.21B$74.44B$75.20B
Shareholders' equity$52.13B$47.66B$38.60B$36.69B$35.80B

As ABBOTT LABORATORIES tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 20, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 31-for-29Stock splitMay 3, 2004
  • 2-for-1Stock splitJun 1, 1998
  • 2-for-1Stock splitJun 1, 1992
  • 2-for-1Stock splitJun 1, 1990
  • 2-for-1Stock splitJun 2, 1986

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 5.02Officer / director changeNov 16, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsOct 21, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsOct 21, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsAug 20, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsJul 16, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 5.03, 5.07, 9.01Officer / director change · Bylaw amendment · Shareholder voteApr 27, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsApr 17, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsApr 16, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsMar 23, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 2.03, 9.01Material agreement · Direct financial obligationMar 9, 2026
    EDGAR ↗

About ABBOTT LABORATORIES

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersABBOTT PARK, IL
IncorporatedIL